Trimethylamine N-Oxide as a Potential Risk Factor for Non-communicable Diseases: A Systematic Review

Boutayeb, A.; Boutayeb, S. The burden of non communicable diseases in developing countries. Int. J. Equity Health, 2005, 4(1), 2.
[http://dx.doi.org/10.1186/1475-9276-4-2] [PMID: 15651987]

Finlay, B.B.; Humans, C. Are noncommunicable diseases communicable? Science, 2020, 367(6475), 250-251.
[http://dx.doi.org/10.1126/science.aaz3834] [PMID: 31949069]

Stanaway, J.D.; Afshin, A.; Gakidou, E.; Lim, S.S.; Abate, D.; Abate, K.H.; Abbafati, C.; Abbasi, N.; Abbastabar, H.; Abd-Allah, F.; Abdela, J.; Abdelalim, A.; Abdollahpour, I.; Abdulkader, R.S.; Abebe, M.; Abebe, Z.; Abera, S.F.; Abil, O.Z.; Abraha, H.N.; Abrham, A.R.; Abu, R.L.J.; Abu, R.N.M.E.; Accrombessi, M.M.K.; Acharya, D.; Acharya, P.; Adamu, A.A.; Adane, A.A.; Adebayo, O.M.; Adedoyin, R.A.; Adekanmbi, V.; Ademi, Z.; Adetokunboh, O.O.; Adib, M.G.; Admasie, A.; Adsuar, J.C.; Afanvi, K.A.; Afarideh, M.; Agarwal, G.; Aggarwal, A.; Aghayan, S.A.; Agrawal, A.; Agrawal, S.; Ahmadi, A.; Ahmadi, M.; Ahmadieh, H.; Ahmed, M.B.; Aichour, A.N.; Aichour, I.; Aichour, M.T.E.; Akbari, M.E.; Akinyemiju, T.; Akseer, N.; Al-Aly, Z.; Al-Eyadhy, A.; Al-Mekhlafi, H.M.; Alahdab, F.; Alam, K.; Alam, S.; Alam, T.; Alashi, A.; Alavian, S.M.; Alene, K.A.; Ali, K.; Ali, S.M.; Alijanzadeh, M.; Alizadeh, N.R.; Aljunid, S.M.; Alkerwi, A.; Alla, F.; Alsharif, U.; Altirkawi, K.; Alvis, G.N.; Amare, A.T.; Ammar, W.; Anber, N.H.; Anderson, J.A.; Andrei, C.L.; Androudi, S.; Animut, M.D.; Anjomshoa, M.; Ansha, M.G.; Antó, J.M.; Antonio, C.A.T.; Anwari, P.; Appiah, L.T.; Appiah, S.C.Y.; Arabloo, J.; Aremu, O.; Ärnlöv, J.; Artaman, A.; Aryal, K.K.; Asayesh, H.; Ataro, Z.; Ausloos, M.; Avokpaho, E.F.G.A.; Awasthi, A.; Ayala Quintanilla, B.P.; Ayer, R.; Ayuk, T.B.; Azzopardi, P.S.; Babazadeh, A.; Badali, H.; Badawi, A.; Balakrishnan, K.; Bali, A.G.; Ball, K.; Ballew, S.H.; Banach, M.; Banoub, J.A.M.; Barac, A.; Barker, C.S.L.; Bärnighausen, T.W.; Barrero, L.H.; Basu, S.; Baune, B.T.; Bazargan, H.S.; Bedi, N.; Beghi, E.; Behzadifar, M.; Behzadifar, M.; Béjot, Y.; Bekele, B.B.; Bekru, E.T.; Belay, E.; Belay, Y.A.; Bell, M.L.; Bello, A.K.; Bennett, D.A.; Bensenor, I.M.; Bergeron, G.; Berhane, A.; Bernabe, E.; Bernstein, R.S.; Beuran, M.; Beyranvand, T.; Bhala, N.; Bhalla, A.; Bhattarai, S.; Bhutta, Z.A.; Biadgo, B.; Bijani, A.; Bikbov, B.; Bilano, V.; Bililign, N.; Bin Sayeed, M.S.; Bisanzio, D.; Biswas, T.; Bjørge, T.; Blacker, B.F.; Bleyer, A.; Borschmann, R.; Bou, O.I.R.; Boufous, S.; Bourne, R.; Brady, O.J.; Brauer, M.; Brazinova, A.; Breitborde, N.J.K.; Brenner, H.; Briko, A.N.; Britton, G.; Brugha, T.; Buchbinder, R.; Burnett, R.T.; Busse, R.; Butt, Z.A.; Cahill, L.E.; Cahuana, H.L.; Campos, N.I.R.; Cárdenas, R.; Carreras, G.; Carrero, J.J.; Carvalho, F.; Castañeda, O.C.A.; Castillo, R.J.; Castro, F.; Catalá, L.F.; Causey, K.; Cercy, K.M.; Cerin, E.; Chaiah, Y.; Chang, H.Y.; Chang, J.C.; Chang, K.L.; Charlson, F.J.; Chattopadhyay, A.; Chattu, V.K.; Chee, M.L.; Cheng, C.Y.; Chew, A.; Chiang, P.P.C.; Chimed, O.O.; Chin, K.L.; Chitheer, A.; Choi, J.Y.J.; Chowdhury, R.; Christensen, H.; Christopher, D.J.; Chung, S-C.; Cicuttini, F.M.; Cirillo, M.; Cohen, A.J.; Collado, M.D.; Cooper, C.; Cooper, O.R.; Coresh, J.; Cornaby, L.; Cortesi, P.A.; Cortinovis, M.; Costa, M.; Cousin, E.; Criqui, M.H.; Cromwell, E.A.; Cundiff, D.K.; Daba, A.K.; Dachew, B.A.; Dadi, A.F.; Damasceno, A.A.M.; Dandona, L.; Dandona, R.; Darby, S.C.; Dargan, P.I.; Daryani, A.; Das Gupta, R.; Das Neves, J.; Dasa, T.T.; Dash, A.P.; Davitoiu, D.V.; Davletov, K.; De La Cruz, G.V.; De La Hoz, F.P.; De Leo, D.; De Neve, J-W.; Degenhardt, L.; Deiparine, S.; Dellavalle, R.P.; Demoz, G.T.; Denova, G.E.; Deribe, K.; Dervenis, N.; Deshpande, A.; Des Jarlais, D.C.; Dessie, G.A.; Deveber, G.A.; Dey, S.; Dharmaratne, S.D.; Dhimal, M.; Dinberu, M.T.; Ding, E.L.; Diro, H.D.; Djalalinia, S.; Do, H.P.; Dokova, K.; Doku, D.T.; Doyle, K.E.; Driscoll, T.R.; Dubey, M.; Dubljanin, E.; Duken, E.E.; Duncan, B.B.; Duraes, A.R.; Ebert, N.; Ebrahimi, H.; Ebrahimpour, S.; Edvardsson, D.; Effiong, A.; Eggen, A.E.; El Bcheraoui, C.; El-Khatib, Z.; Elyazar, I.R.; Enayati, A.; Endries, A.Y.; Er, B.; Erskine, H.E.; Eskandarieh, S.; Esteghamati, A.; Estep, K.; Fakhim, H.; Faramarzi, M.; Fareed, M.; Farid, T.A.; Farinha, C.S.E.; Farioli, A.; Faro, A.; Farvid, M.S.; Farzaei, M.H.; Fatima, B.; Fay, K.A.; Fazaeli, A.A.; Feigin, V.L.; Feigl, A.B.; Fereshtehnejad, S.M.; Fernandes, E.; Fernandes, J.C.; Ferrara, G.; Ferrari, A.J.; Ferreira, M.L.; Filip, I.; Finger, J.D.; Fischer, F.; Foigt, N.A.; Foreman, K.J.; Fukumoto, T.; Fullman, N.; Fürst, T.; Furtado, J.M.; Futran, N.D.; Gall, S.; Gallus, S.; Gamkrelidze, A.; Ganji, M.; Garcia, B.A.L.; Gardner, W.M.; Gebre, A.K.; Gebremedhin, A.T.; Gebremichael, T.G.; Gelano, T.F.; Geleijnse, J.M.; Geramo, Y.C.D.; Gething, P.W.; Gezae, K.E.; Ghadimi, R.; Ghadiri, K.; Ghasemi, F.K.; Ghasemi, K.M.; Ghimire, M.; Ghosh, R.; Ghoshal, A.G.; Giampaoli, S.; Gill, P.S.; Gill, T.K.; Gillum, R.F.; Ginawi, I.A.; Giussani, G.; Gnedovskaya, E.V.; Godwin, W.W.; Goli, S.; Gómez, D.H.; Gona, P.N.; Gopalani, S.V.; Goulart, A.C.; Grada, A.; Grams, M.E.; Grosso, G.; Gugnani, H.C.; Guo, Y.; Gupta, R.; Gupta, R.; Gupta, T.; Gutiérrez, R.A.; Gutiérrez, T.D.S.; Haagsma, J.A.; Habtewold, T.D.; Hachinski, V.; Hafezi, N.N.; Hagos, T.B.; Hailegiyorgis, T.T.; Hailu, G.B.; Haj-Mirzaian, A.; Haj-Mirzaian, A.; Hamadeh, R.R.; Hamidi, S.; Handal, A.J.; Hankey, G.J.; Hao, Y.; Harb, H.L.; Harikrishnan, S.; Haro, J.M.; Hassankhani, H.; Hassen, H.Y.; Havmoeller, R.; Hawley, C.N.; Hay, S.I.; Hedayatizadeh-Omran, A.; Heibati, B.; Heidari, B.; Heidari, M.; Hendrie, D.; Henok, A.; Heredia-Pi, I.; Herteliu, C.; Heydarpour, F.; Heydarpour, S.; Hibstu, D.T.; Higazi, T.B.; Hilawe, E.H.; Hoek, H.W.; Hoffman, H.J.; Hole, M.K.; Homaie Rad, E.; Hoogar, P.; Hosgood, H.D.; Hosseini, S.M.; Hosseinzadeh, M.; Hostiuc, M.; Hostiuc, S.; Hoy, D.G.; Hsairi, M.; Hsiao, T.; Hu, G.; Hu, H.; Huang, J.J.; Hussen, M.A.; Huynh, C.K.; Iburg, K.M.; Ikeda, N.; Ilesanmi, O.S.; Iqbal, U.; Irvani, S.S.N.; Irvine, C.M.S.; Islam, S.M.S.; Islami, F.; Jackson, M.D.; Jacobsen, K.H.; Jahangiry, L.; Jahanmehr, N.; Jain, S.K.; Jakovljevic, M.; James, S.L.; Jassal, S.K.; Jayatilleke, A.U.; Jeemon, P.; Jha, R.P.; Jha, V.; Ji, J.S.; Jonas, J.B.; Jonnagaddala, J.; Jorjoran Shushtari, Z.; Joshi, A.; Jozwiak, J.J.; Jürisson, M.; Kabir, Z.; Kahsay, A.; Kalani, R.; Kanchan, T.; Kant, S.; Kar, C.; Karami, M.; Karami Matin, B.; Karch, A.; Karema, C.; Karimi, N.; Karimi, S.M.; Kasaeian, A.; Kassa, D.H.; Kassa, G.M.; Kassa, T.D.; Kassebaum, N.J.; Katikireddi, S.V.; Kaul, A.; Kawakami, N.; Kazemi, Z.; Karyani, A.K.; Kefale, A.T.; Keiyoro, P.N.; Kemp, G.R.; Kengne, A.P.; Keren, A.; Kesavachandran, C.N.; Khader, Y.S.; Khafaei, B.; Khafaie, M.A.; Khajavi, A.; Khalid, N.; Khalil, I.A.; Khan, G.; Khan, M.S.; Khan, M.A.; Khang, Y-H.; Khater, M.M.; Khazaei, M.; Khazaie, H.; Khoja, A.T.; Khosravi, A.; Khosravi, M.H.; Kiadaliri, A.A.; Kiirithio, D.N.; Kim, C-I.; Kim, D.; Kim, Y-E.; Kim, Y.J.; Kimokoti, R.W.; Kinfu, Y.; Kisa, A.; Kissimova-Skarbek, K.; Kivimäki, M.; Knibbs, L.D.; Knudsen, A.K.S.; Kochhar, S.; Kokubo, Y.; Kolola, T.; Kopec, J.A.; Kosen, S.; Koul, P.A.; Koyanagi, A.; Kravchenko, M.A.; Krishan, K.; Krohn, K.J.; Kromhout, H.; Kuate Defo, B.; Kucuk Bicer, B.; Kumar, G.A.; Kumar, M.; Kuzin, I.; Kyu, H.H.; Lachat, C.; Lad, D.P.; Lad, S.D.; Lafranconi, A.; Lalloo, R.; Lallukka, T.; Lami, F.H.; Lang, J.J.; Lansingh, V.C.; Larson, S.L.; Latifi, A.; Lazarus, J.V.; Lee, P.H.; Leigh, J.; Leili, M.; Leshargie, C.T.; Leung, J.; Levi, M.; Lewycka, S.; Li, S.; Li, Y.; Liang, J.; Liang, X.; Liao, Y.; Liben, M.L.; Lim, L-L.; Linn, S.; Liu, S.; Lodha, R.; Logroscino, G.; Lopez, A.D.; Lorkowski, S.; Lotufo, P.A.; Lozano, R.; Lucas, T.C.D.; Lunevicius, R.; Ma, S.; Macarayan, E.R.K.; Machado, Í.E.; Madotto, F.; Mai, H.T.; Majdan, M.; Majdzadeh, R.; Majeed, A.; Malekzadeh, R.; Malta, D.C.; Mamun, A.A.; Manda, A-L.; Manguerra, H.; Mansournia, M.A.; Mantovani, L.G.; Maravilla, J.C.; Marcenes, W.; Marks, A.; Martin, R.V.; Martins, S.C.O.; Martins, M.F.R.; März, W.; Marzan, M.B.; Massenburg, B.B.; Mathur, M.R.; Mathur, P.; Matsushita, K.; Maulik, P.K.; Mazidi, M.; McAlinden, C.; McGrath, J.J.; McKee, M.; Mehrotra, R.; Mehta, K.M.; Mehta, V.; Meier, T.; Mekonnen, F.A.; Melaku, Y.A.; Melese, A.; Melku, M.; Memiah, P.T.N.; Memish, Z.A.; Mendoza, W.; Mengistu, D.T.; Mensah, G.A.; Mensink, G.B.M.; Mereta, S.T.; Meretoja, A.; Meretoja, T.J.; Mestrovic, T.; Mezgebe, H.B.; Miazgowski, B.; Miazgowski, T.; Millear, A.I.; Miller, T.R.; Miller-Petrie, M.K.; Mini, G.K.; Mirarefin, M.; Mirica, A.; Mirrakhimov, E.M.; Misganaw, A.T.; Mitiku, H.; Moazen, B.; Mohajer, B.; Mohammad, K.A.; Mohammadi, M.; Mohammadifard, N.; Mohammadnia-Afrouzi, M.; Mohammed, S.; Mohebi, F.; Mokdad, A.H.; Molokhia, M.; Momeniha, F.; Monasta, L.; Moodley, Y.; Moradi, G.; Moradi-Lakeh, M.; Moradinazar, M.; Moraga, P.; Morawska, L.; Morgado-Da-Costa, J.; Morrison, S.D.; Moschos, M.M.; Mouodi, S.; Mousavi, S.M.; Mozaffarian, D.; Mruts, K.B.; Muche, A.A.; Muchie, K.F.; Mueller, U.O.; Muhammed, O.S.; Mukhopadhyay, S.; Muller, K.; Musa, K.I.; Mustafa, G.; Nabhan, A.F.; Naghavi, M.; Naheed, A.; Nahvijou, A.; Naik, G.; Naik, N.; Najafi, F.; Nangia, V.; Nansseu, J.R.; Nascimento, B.R.; Neal, B.; Neamati, N.; Negoi, I.; Negoi, R.I.; Neupane, S.; Newton, C.R.J.; Ngunjiri, J.W.; Nguyen, A.Q.; Nguyen, G.; Nguyen, H.T.; Nguyen, H.L.T.; Nguyen, H.T.; Nguyen, M.; Nguyen, N.B.; Nichols, E.; Nie, J.; Ningrum, D.N.A.; Nirayo, Y.L.; Nishi, N.; Nixon, M.R.; Nojomi, M.; Nomura, S.; Norheim, O.F.; Noroozi, M.; Norrving, B.; Noubiap, J.J.; Nouri, H.R.; Nourollahpour Shiadeh, M.; Nowroozi, M.R.; Nsoesie, E.O.; Nyasulu, P.S.; Obermeyer, C.M.; Odell, C.M.; Ofori-Asenso, R.; Ogbo, F.A.; Oh, I-H.; Oladimeji, O.; Olagunju, A.T.; Olagunju, T.O.; Olivares, P.R.; Olsen, H.E.; Olusanya, B.O.; Olusanya, J.O.; Ong, K.L.; Ong, S.K.; Oren, E.; Orpana, H.M.; Ortiz, A.; Ota, E.; Otstavnov, S.S.; Øverland, S.; Owolabi, M.O.; P A, M.; Pacella, R.; Pakhare, A.P.; Pakpour, A.H.; Pana, A.; Panda-Jonas, S.; Park, E-K.; Parry, C.D.H.; Parsian, H.; Patel, S.; Pati, S.; Patil, S.T.; Patle, A.; Patton, G.C.; Paudel, D.; Paulson, K.R.; Paz Ballesteros, W.C.; Pearce, N.; Pereira, A.; Pereira, D.M.; Perico, N.; Pesudovs, K.; Petzold, M.; Pham, H.Q.; Phillips, M.R.; Pillay, J.D.; Piradov, M.A.; Pirsaheb, M.; Pischon, T.; Pishgar, F.; Plana-Ripoll, O.; Plass, D.; Polinder, S.; Polkinghorne, K.R.; Postma, M.J.; Poulton, R.; Pourshams, A.; Poustchi, H.; Prabhakaran, D.; Prakash, S.; Prasad, N.; Purcell, C.A.; Purwar, M.B.; Qorbani, M.; Radfar, A.; Rafay, A.; Rafiei, A.; Rahim, F.; Rahimi, Z.; Rahimi-Movaghar, A.; Rahimi-Movaghar, V.; Rahman, M.; Rahman, M.H.; Rahman, M.A.; Rai, R.K.; Rajati, F.; Rajsic, S.; Raju, S.B.; Ram, U.; Ranabhat, C.L.; Ranjan, P.; Rath, G.K.; Rawaf, D.L.; Rawaf, S.; Reddy, K.S.; Rehm, C.D.; Rehm, J.; Reiner, R.C., Jr; Reitsma, M.B.; Remuzzi, G.; Renzaho, A.M.N.; Resnikoff, S.; Reynales, S.L.M.; Rezaei, S.; Ribeiro, A.L.P.; Rivera, J.A.; Roba, K.T.; Rodríguez-Ramírez, S.; Roever, L.; Román, Y.; Ronfani, L.; Roshandel, G.; Rostami, A.; Roth, G.A.; Rothenbacher, D.; Roy, A.; Rubagotti, E.; Rushton, L.; Sabanayagam, C.; Sachdev, P.S.; Saddik, B.; Sadeghi, E.; Saeedi Moghaddam, S.; Safari, H.; Safari, Y.; Safari-Faramani, R.; Safdarian, M.; Safi, S.; Safiri, S.; Sagar, R.; Sahebkar, A.; Sahraian, M.A.; Sajadi, H.S.; Salam, N.; Salamati, P.; Saleem, Z.; Salimi, Y.; Salimzadeh, H.; Salomon, J.A.; Salvi, D.D.; Salz, I.; Samy, A.M.; Sanabria, J.; Sanchez-Niño, M.D.; Sánchez-Pimienta, T.G.; Sanders, T.; Sang, Y.; Santomauro, D.F.; Santos, I.S.; Santos, J.V.; Santric Milicevic, M.M.; Sao Jose, B.P.; Sardana, M.; Sarker, A.R.; Sarmiento-Suárez, R.; Sarrafzadegan, N.; Sartorius, B.; Sarvi, S.; Sathian, B.; Satpathy, M.; Sawant, A.R.; Sawhney, M.; Saylan, M.; Sayyah, M.; Schaeffner, E.; Schmidt, M.I.; Schneider, I.J.C.; Schöttker, B.; Schutte, A.E.; Schwebel, D.C.; Schwendicke, F.; Scott, J.G.; Seedat, S.; Sekerija, M.; Sepanlou, S.G.; Serre, M.L.; Serván-Mori, E.; Seyedmousavi, S.; Shabaninejad, H.; Shaddick, G.; Shafieesabet, A.; Shahbazi, M.; Shaheen, A.A.; Shaikh, M.A.; Shamah Levy, T.; Shams-Beyranvand, M.; Shamsi, M.; Sharafi, H.; Sharafi, K.; Sharif, M.; Sharif-Alhoseini, M.; Sharifi, H.; Sharma, J.; Sharma, M.; Sharma, R.; She, J.; Sheikh, A.; Shi, P.; Shibuya, K.; Shiferaw, M.S.; Shigematsu, M.; Shin, M-J.; Shiri, R.; Shirkoohi, R.; Shiue, I.; Shokraneh, F.; Shoman, H.; Shrime, M.G.; Shupler, M.S.; Si, S.; Siabani, S.; Sibai, A.M.; Siddiqi, T.J.; Sigfusdottir, I.D.; Sigurvinsdottir, R.; Silva, D.A.S.; Silva, J.P.; Silveira, D.G.A.; Singh, J.A.; Singh, N.P.; Singh, V.; Sinha, D.N.; Skiadaresi, E.; Skirbekk, V.; Smith, D.L.; Smith, M.; Sobaih, B.H.; Sobhani, S.; Somayaji, R.; Soofi, M.; Sorensen, R.J.D.; Soriano, J.B.; Soyiri, I.N.; Spinelli, A.; Sposato, L.A.; Sreeramareddy, C.T.; Srinivasan, V.; Starodubov, V.I.; Steckling, N.; Stein, D.J.; Stein, M.B.; Stevanovic, G.; Stockfelt, L.; Stokes, M.A.; Sturua, L.; Subart, M.L.; Sudaryanto, A.; Sufiyan, M.B.; Sulo, G.; Sunguya, B.F.; Sur, P.J.; Sykes, B.L.; Szoeke, C.E.I.; Tabarés, S.R.; Tabuchi, T.; Tadakamadla, S.K.; Takahashi, K.; Tandon, N.; Tassew, S.G.; Tavakkoli, M.; Taveira, N.; Tehrani, B.A.; Tekalign, T.G.; Tekelemedhin, S.W.; Tekle, M.G.; Temesgen, H.; Temsah, M.H.; Temsah, O.; Terkawi, A.S.; Tessema, B.; Teweldemedhin, M.; Thankappan, K.R.; Theis, A.; Thirunavukkarasu, S.; Thomas, H.J.; Thomas, M.L.; Thomas, N.; Thurston, G.D.; Tilahun, B.; Tillmann, T.; To, Q.G.; Tobollik, M.; Tonelli, M.; Topor, M.R.; Torre, A.E.; Tortajada, G.M.; Touvier, M.; Tovani, P.M.R.; Towbin, J.A.; Tran, B.X.; Tran, K.B.; Truelsen, T.C.; Truong, N.T.; Tsadik, A.G.; Tudor Car, L.; Tuzcu, E.M.; Tymeson, H.D.; Tyrovolas, S.; Ukwaja, K.N.; Ullah, I.; Updike, R.L.; Usman, M.S.; Uthman, O.A.; Vaduganathan, M.; Vaezi, A.; Valdez, P.R.; Van Donkelaar, A.; Varavikova, E.; Varughese, S.; Vasankari, T.J.; Venkateswaran, V.; Venketasubramanian, N.; Villafaina, S.; Violante, F.S.; Vladimirov, S.K.; Vlassov, V.; Vollset, S.E.; Vos, T.; Vosoughi, K.; Vu, G.T.; Vujcic, I.S.; Wagnew, F.S.; Waheed, Y.; Waller, S.G.; Walson, J.L.; Wang, Y.; Wang, Y.; Wang, Y.P.; Weiderpass, E.; Weintraub, R.G.; Weldegebreal, F.; Werdecker, A.; Werkneh, A.A.; West, J.J.; Westerman, R.; Whiteford, H.A.; Widecka, J.; Wijeratne, T.; Winkler, A.S.; Wiyeh, A.B.; Wiysonge, C.S.; Wolfe, C.D.A.; Wong, T.Y.; Wu, S.; Xavier, D.; Xu, G.; Yadgir, S.; Yadollahpour, A.; Yahyazadeh Jabbari, S.H.; Yamada, T.; Yan, L.L.; Yano, Y.; Yaseri, M.; Yasin, Y.J.; Yeshaneh, A.; Yimer, E.M.; Yip, P.; Yisma, E.; Yonemoto, N.; Yoon, S-J.; Yotebieng, M.; Younis, M.Z.; Yousefifard, M.; Yu, C.; Zaidi, Z.; Zaman, S.B.; Zamani, M.; Zavala, A.L.; Zhang, A.L.; Zhang, H.; Zhang, K.; Zhou, M.; Zimsen, S.R.M.; Zodpey, S.; Murray, C.J.L. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392(10159), 1923-1994.
[http://dx.doi.org/10.1016/S0140-6736(18)32225-6] [PMID: 30496105]

Organization, W.H. Noncommunicable diseases country profiles; , 2018. Available from: https://apps.who.int/iris/handle/10665/274512

Subramaniam, S.; Fletcher, C. Trimethylamine N-oxide: Breathe new life. Br. J. Pharmacol., 2018, 175(8), 1344-1353.
[http://dx.doi.org/10.1111/bph.13959] [PMID: 28745401]

Ejtahed, HS.; Soroush, AR.; Angoorani, P.; Larijani, B.; Hasani, RS. Gut microbiota as a target in the pathogenesis of metabolic disorders: A new approach to novel therapeutic agents. Horm. Metab. Res., 2016, 48(6), 349-358.
[http://dx.doi.org/10.1055/s-0042-107792]

Chen, Y.; Liu, Y.; Zhou, R.; Chen, X.; Wang, C.; Tan, X.; Wang, L.; Zheng, R.; Zhang, H.; Ling, W.; Zhu, H. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults. Sci. Rep., 2016, 6(1), 19076.
[http://dx.doi.org/10.1038/srep19076] [PMID: 26743949]

Guertin, K.A.; Li, X.S.; Graubard, B.I.; Albanes, D.; Weinstein, S.J.; Goedert, J.J.; Wang, Z.; Hazen, S.L.; Sinha, R. Serum trimethylamine n-oxide, carnitine, choline, and betaine in relation to colorectal cancer risk in the alpha tocopherol, beta carotene cancer prevention study. Cancer Epidemiol. Biomarkers Prev., 2017, 26(6), 945-952.
[http://dx.doi.org/10.1158/1055-9965.EPI-16-0948] [PMID: 28077427]

Shanahan, F. The gut microbiota—a clinical perspective on lessons learned. Nat. Rev. Gastroenterol. Hepatol., 2012, 9(10), 609-614.
[http://dx.doi.org/10.1038/nrgastro.2012.145] [PMID: 22890109]

Smirnov, K.S.; Maier, T.V.; Walker, A.; Heinzmann, S.S.; Forcisi, S.; Martinez, I.; Walter, J.; Schmitt, K.P. Challenges of metabolomics in human gut microbiota research. Int. J. Med. Microbiol., 2016, 306(5), 266-279.
[http://dx.doi.org/10.1016/j.ijmm.2016.03.006] [PMID: 27012595]

Cho, C.E.; Caudill, M.A. Trimethylamine-N-oxide: Friend, foe, or simply caught in the cross-fire? Trends Endocrinol. Metab., 2017, 28(2), 121-130.
[http://dx.doi.org/10.1016/j.tem.2016.10.005] [PMID: 27825547]

Hoseini, T.Z.; Hasani, R.S. Targeting TMAO and its metabolic pathway for cardiovascular diseases treatment. J. Diabetes Metab. Disord., 2021, 20(1), 1095-1097.
[http://dx.doi.org/10.1007/s40200-021-00819-x] [PMID: 34178875]

Janeiro, M. Ramírez, M.; Milagro, F.; Martínez, J.; Solas, M. Implication of Trimethylamine N-oxide (TMAO) in disease: Potential biomarker or new therapeutic target. Nutrients, 2018, 10(10), 1398.
[http://dx.doi.org/10.3390/nu10101398] [PMID: 30275434]

Zhuang, R.; Ge, X.; Han, L.; Yu, P.; Gong, X.; Meng, Q.; Zhang, Y.; Fan, H.; Zheng, L.; Liu, Z.; Zhou, X. Gut microbe–generated metabolite trimethylamine N -oxide and the risk of diabetes: A systematic review and dose-response meta-analysis. Obes. Rev., 2019, 20(6), 883-894.
[http://dx.doi.org/10.1111/obr.12843] [PMID: 30868721]

Farhangi, M.A.; Vajdi, M.; Asghari, J.M. Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: A systematic review and dose–response meta-analysis. Nutr. J., 2020, 19(1), 76.
[http://dx.doi.org/10.1186/s12937-020-00592-2] [PMID: 32731904]

Yao, M.E.; Liao, P.D.; Zhao, X.J.; Wang, L. Trimethylamine-N-oxide has prognostic value in coronary heart disease: A meta-analysis and dose-response analysis. BMC Cardiovasc. Disord., 2020, 20(1), 7.
[http://dx.doi.org/10.1186/s12872-019-01310-5] [PMID: 31918665]

Qi, J.; You, T.; Li, J.; Pan, T.; Xiang, L.; Han, Y.; Zhu, L. Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: A systematic review and meta-analysis of 11 prospective cohort studies. J. Cell. Mol. Med., 2018, 22(1), 185-194.
[http://dx.doi.org/10.1111/jcmm.13307] [PMID: 28782886 ]

Schiattarella, G.G.; Sannino, A.; Toscano, E.; Giugliano, G.; Gargiulo, G.; Franzone, A.; Trimarco, B.; Esposito, G.; Perrino, C. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: A systematic review and dose-response meta-analysis. Eur. Heart J., 2017, 38(39), 2948-2956.
[http://dx.doi.org/10.1093/eurheartj/ehx342] [PMID: 29020409]

Ge, X.; Zheng, L.; Zhuang, R.; Yu, P.; Xu, Z.; Liu, G.; Xi, X.; Zhou, X.; Fan, H. The gut microbial metabolite trimethylamine N-oxide and hypertension risk: A systematic review and dose-response meta-analysis. Adv. Nutr., 2020, 11(1), 66-76.
[PMID: 31269204]

Abbasalizad, F.M.; Vajdi, M. Gut microbiota–associated trimethylamine N-oxide and increased cardiometabolic risk in adults: A systematic review and dose-response meta-analysis. Nutr. Rev., 2020, 79(9), 1022-1042.
[PMID: 33270896]

Guasti, L.; Galliazzo, S.; Molaro, M.; Visconti, E.; Pennella, B.; Gaudio, G.V.; Lupi, A.; Grandi, A.M.; Squizzato, A. TMAO as a biomarker of cardiovascular events: A systematic review and meta-analysis. Intern. Emerg. Med., 2021, 16(1), 201-207.
[http://dx.doi.org/10.1007/s11739-020-02470-5] [PMID: 32779113]

Lever, M.; George, P.M.; Slow, S.; Bellamy, D.; Young, J.M.; Ho, M.; McEntyre, C.J.; Elmslie, J.L.; Atkinson, W.; Molyneux, S.L.; Troughton, R.W.; Frampton, C.M.; Richards, A.M.; Chambers, S.T. Betaine and trimethylamine-N-oxide as predictors of cardiovascular outcomes show different patterns in diabetes mellitus: An observational study. PLoS One, 2014, 9(12), e114969.
[http://dx.doi.org/10.1371/journal.pone.0114969] [PMID: 25493436]

McEntyre, C.J.; Lever, M.; Chambers, S.T.; George, P.M.; Slow, S.; Elmslie, J.L.; Florkowski, C.M.; Lunt, H.; Krebs, J.D. Variation of betaine, N,N- dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine- N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. Ann. Clin. Biochem., 2015, 52(3), 352-360.
[http://dx.doi.org/10.1177/0004563214545346] [PMID: 25013088]

Obeid, R.; Awwad, H.M.; Rabagny, Y.; Graeber, S.; Herrmann, W.; Geisel, J. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism. Am. J. Clin. Nutr., 2016, 103(3), 703-711.
[http://dx.doi.org/10.3945/ajcn.115.121269] [PMID: 26864355]

Al-Obaide, M.; Singh, R.; Datta, P.; Rewers, F.K.; Salguero, M.; Al-Obaidi, I.; Kottapalli, K.; Vasylyeva, T. Gut microbiota-dependent trimethylamine-N-oxide and serum biomarkers in patients with T2DM and advanced CKD. J. Clin. Med., 2017, 6(9), 86.
[http://dx.doi.org/10.3390/jcm6090086] [PMID: 28925931]

Shan, Z.; Sun, T.; Huang, H.; Chen, S.; Chen, L.; Luo, C.; Yang, W.; Yang, X.; Yao, P.; Cheng, J.; Hu, F.B.; Liu, L. Association between microbiota-dependent metabolite trimethylamine- N -oxide and type 2 diabetes. Am. J. Clin. Nutr., 2017, 106(3), ajcn157107.
[http://dx.doi.org/10.3945/ajcn.117.157107] [PMID: 28724646]

Tang, W.H.W.; Wang, Z.; Li, X.S.; Fan, Y.; Li, D.S.; Wu, Y.; Hazen, S.L. Increased trimethylamine N-oxide portends high mortality risk independent of glycemic control in patients with type 2 diabetes mellitus. Clin. Chem., 2017, 63(1), 297-306.
[http://dx.doi.org/10.1373/clinchem.2016.263640] [PMID: 27864387]

Dong, Z.; Liang, Z.; Guo, M.; Hu, S.; Shen, Z.; Hai, X. The association between plasma levels of trimethylamine N-oxide and the risk of coronary heart disease in Chinese patients with or without type 2 diabetes mellitus. Dis. Markers, 2018, 2018, 1578320.
[http://dx.doi.org/10.1155/2018/1578320] [PMID: 30159101]

Li, P.; Zhong, C.; Li, S.; Sun, T.; Huang, H.; Chen, X.; Zhu, Y.; Hu, X.; Peng, X.; Zhang, X.; Bao, W.; Shan, Z.; Cheng, J.; Hu, F.B.; Yang, N.; Liu, L. Plasma concentration of trimethylamine-N-oxide and risk of gestational diabetes mellitus. Am. J. Clin. Nutr., 2018, 108(3), 603-610.
[http://dx.doi.org/10.1093/ajcn/nqy116] [PMID: 30535087]

Papandreou, C.; Bulló, M.; Zheng, Y.; Ruiz, C.M.; Yu, E.; Guasc, F.M.; Toledo, E.; Clish, C.; Corella, D.; Estruch, R.; Ros, E.; Fitó, M.; Arós, F.; Fiol, M.; Lapetra, J.; Serra, M.L.; Gómez, G.E.; Liang, L.; Fragkiadakis, G.A.; Razquin, C.; Hu, F.B.; Salas, S.J. Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial. Am. J. Clin. Nutr., 2018, 108(1), 163-173.
[http://dx.doi.org/10.1093/ajcn/nqy058] [PMID: 29982310]

Cardona, A.; O’Brien, A.; Bernier, M.C.; Somogyi, A.; Wysocki, V.H.; Smart, S.; He, X.; Ambrosio, G.; Hsueh, W.A.; Raman, S.V. Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: An accord trial post hoc analysis. BMJ Open Diabetes Res. Care, 2019, 7(1), e000718.
[http://dx.doi.org/10.1136/bmjdrc-2019-000718] [PMID: 31798892]

Garcia, E.; Osté, M.C.J.; Bennett, D.W.; Jeyarajah, E.J.; Shalaurova, I.; Gruppen, E.G.; Hazen, S.L.; Otvos, J.D.; Bakker, S.J.L.; Dullaart, R.P.F.; Connelly, M.A. High betaine, a trimethylamine N-oxide related metabolite, is prospectively associated with low future risk of type 2 diabetes mellitus in the prevend study. J. Clin. Med., 2019, 8(11), 1813.
[http://dx.doi.org/10.3390/jcm8111813] [PMID: 31683780]

Huo, X.; Li, J.; Cao, Y.F.; Li, S.N.; Shao, P.; Leng, J.; Li, W.; Liu, J.; Yang, K.; Ma, R.C.W.; Hu, G.; Fang, Z.Z.; Yang, X. Trimethylamine N-oxide metabolites in early pregnancy and risk of gestational diabetes: A nested case-control study. J. Clin. Endocrinol. Metab., 2019, 104(11), 5529-5539.
[http://dx.doi.org/10.1210/jc.2019-00710] [PMID: 31373635]

Winther, S.A. Øllgaard, J.C.; Tofte, N.; Tarnow, L.; Wang, Z.; Ahluwalia, T.S.; Jorsal, A.; Theilade, S.; Parving, H.H.; Hansen, T.W.; Hazen, S.L.; Pedersen, O.; Rossing, P. Utility of plasma concentration of trimethylamine N-oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes. Diabetes Care, 2019, 42(8), 1512-1520.
[http://dx.doi.org/10.2337/dc19-0048] [PMID: 31123156]

Croyal, M.; Saulnier, P.J.; Aguesse, A.; Gand, E.; Ragot, S.; Roussel, R.; Halimi, J.M.; Ducrocq, G.; Cariou, B.; Montaigne, D.; Wargny, M.; Krempf, M.; Hadjadj, S. Plasma trimethylamine N-oxide and risk of cardiovascular events in patients with type 2 diabetes. J. Clin. Endocrinol. Metab., 2020, 105(7), 2371-2380.
[http://dx.doi.org/10.1210/clinem/dgaa188] [PMID: 32301490]

Roy, S.; Yuzefpolskaya, M.; Nandakumar, R.; Colombo, P.C.; Demmer, R.T. Plasma trimethylamine-N-oxide and impaired glucose regulation: Results from the Oral Infections, Glucose Intolerance and Insulin Resistance Study (ORIGINS). PLoS One, 2020, 15(1), e0227482.
[http://dx.doi.org/10.1371/journal.pone.0227482] [PMID: 31940332]

Bain, M.A.; Faull, R.; Fornasini, G.; Milne, R.W.; Evans, A.M. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol. Dial. Transplant., 2006, 21(5), 1300-1304.
[http://dx.doi.org/10.1093/ndt/gfk056] [PMID: 16401621]

Mueller, D.M.; Allenspach, M.; Othman, A.; Saely, C.H.; Muendlein, A.; Vonbank, A.; Drexel, H.; Von Eckardstein, A. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. Atherosclerosis, 2015, 243(2), 638-644.
[http://dx.doi.org/10.1016/j.atherosclerosis.2015.10.091] [PMID: 26554714]

Tang, W.H.W.; Wang, Z.; Kennedy, D.J.; Wu, Y.; Buffa, J.A.; Agatisa-Boyle, B.; Li, X.S.; Levison, B.S.; Hazen, S.L. Gut microbiota-dependent Trimethylamine N-Oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res., 2015, 116(3), 448-455.
[http://dx.doi.org/10.1161/CIRCRESAHA.116.305360] [PMID: 25599331]

Kim, R.B.; Morse, B.L.; Djurdjev, O.; Tang, M.; Muirhead, N.; Barrett, B.; Holmes, D.T.; Madore, F.; Clase, C.M.; Rigatto, C.; Levin, A.; Agharazii, M.; Blouin, J.; Samson, F.; Akbarii, A.; Cheesman, J.; Courtney, J.; Hamer, S.; Delic, E.; Cronin, V.; Barré, P.; Golden, J.; Barrett, B.; Langille, E.; Adams, S.; Morgan, J.; Clase, C.; Moreau, C.; Cooper, S.; Forzley, B.; Caron, S.; Granger, S.; Valley, S.; Sather, H.; Cournoyer, S.; Menard, L.; Roy, M.; Skidmore, H.; Beaudry, D.; Dionne, J.; Chow, J.; Sahraei, V.; Donnelly, S.; Dacouris, N.; Marticorena, R.; Hemmelgarn, B.; Gulewich, S.; Hamilton, T.; Keown, P.; Zalunardo, N.; Rogers, D.; Tut, R.; Paquette, M.; Yung, R.; Levin, A.; Ferguson, N.; Tang, M.; Chiu, H.; Carlson, K.; Sioson, L.; Perry, T.; Sheriff, Z.; Rozen, N.; Lok, C.; Cross, M.; Forrester, C.; Cotoi, A.; Madore, F.; Maltais, M.; Moist, L.; Gallo, K.; Langford, S.; Slamen, L.; Cram, D.; Muirhead, N.; Edgar, M.J.; Gray, T.; Edgar, C.; Groeneweg, K.; McKinnon, E.; McRae, E.; Blackie, K.; Nathoo, B.; Lau, K.; Parmar, M.; Gelinas, S.; Leblanc, M.; Lépine, L.; Rigatto, C.; Friesen, D.; Soroka, S.; Fleet, S.; Squires, J.; Thanamayooran, S.; Binder, M.; Hines, C.; McNeil, B.; McDougall, P.; Howard, J.; Gillis, D.; Hines, K.; Tobe, S.; Chessman, M.; Perkins, N.; Agelopoulos, M.; Knox, S.; Richards, T.; Tonelli, M.; Szigety, S.; Opgenorth, D.; Yeates, K.; Mahoney, K. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events. Kidney Int., 2016, 89(5), 1144-1152.
[http://dx.doi.org/10.1016/j.kint.2016.01.014] [PMID: 27083288]

Missailidis, C.; Hällqvist, J.; Qureshi, A.R.; Barany, P.; Heimbürger, O.; Lindholm, B.; Stenvinkel, P.; Bergman, P. Serum trimethylamine-N-oxide is strongly related to renal function and predicts outcome in chronic kidney disease. PLoS One, 2016, 11(1), e0141738.
[http://dx.doi.org/10.1371/journal.pone.0141738] [PMID: 26751065]

Stubbs, J.R.; House, J.A.; Ocque, A.J.; Zhang, S.; Johnson, C.; Kimber, C.; Schmidt, K.; Gupta, A.; Wetmore, J.B.; Nolin, T.D.; Spertus, J.A.; Yu, A.S. Serum trimethylamine- N -oxide is elevated in CKD and correlates with coronary atherosclerosis burden. J. Am. Soc. Nephrol., 2016, 27(1), 305-313.
[http://dx.doi.org/10.1681/ASN.2014111063] [PMID: 26229137]

Gruppen, E.G.; Garcia, E.; Connelly, M.A.; Jeyarajah, E.J.; Otvos, J.D.; Bakker, S.J.L.; Dullaart, R.P.F. TMAO is associated with mortality: Impact of modestly impaired renal function. Sci. Rep., 2017, 7(1), 13781.
[http://dx.doi.org/10.1038/s41598-017-13739-9] [PMID: 29061990]

Shafi, T.; Powe, N.R.; Meyer, T.W.; Hwang, S.; Hai, X.; Melamed, M.L.; Banerjee, T.; Coresh, J.; Hostetter, T.H. Trimethylamine N -oxide and cardiovascular events in hemodialysis patients. J. Am. Soc. Nephrol., 2017, 28(1), 321-331.
[http://dx.doi.org/10.1681/ASN.2016030374] [PMID: 27436853]

Xu, K.Y.; Xia, G.H.; Lu, J.Q.; Chen, M.X.; Zhen, X.; Wang, S.; You, C.; Nie, J.; Zhou, H.W.; Yin, J. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Sci. Rep., 2017, 7(1), 1445.
[http://dx.doi.org/10.1038/s41598-017-01387-y] [PMID: 28469156]

Hsu, C.N.; Lu, P.C.; Lo, M.H.; Lin, I.C.; Chang-Chien, G.P.; Lin, S.; Tain, Y.L. Gut microbiota-dependent trimethylamine N-oxide pathway associated with cardiovascular risk in children with early-stage chronic kidney disease. Int. J. Mol. Sci., 2018, 19(12), 3699.
[http://dx.doi.org/10.3390/ijms19123699] [PMID: 30469463]

Stubbs, J.R.; Stedman, M.R.; Liu, S.; Long, J.; Franchetti, Y.; West, R.E., III; Prokopienko, A.J.; Mahnken, J.D.; Chertow, G.M.; Nolin, T.D. Trimethylamine N-oxide and cardiovascular outcomes in patients with ESKD receiving maintenance hemodialysis. Clin. J. Am. Soc. Nephrol., 2019, 14(2), 261-267.
[http://dx.doi.org/10.2215/CJN.06190518] [PMID: 30665924]

Guo, F.; Qiu, X.; Tan, Z.; Li, Z.; Ouyang, D. Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction. BMC Cardiovasc. Disord., 2020, 20(1), 394.
[http://dx.doi.org/10.1186/s12872-020-01669-w] [PMID: 32859154]

Hsu, C.N.; Chang, C.G.P.; Lin, S.; Hou, C.Y.; Lu, P.C.; Tain, Y.L. Association of trimethylamine, trimethylamine N-oxide, and dimethylamine with cardiovascular risk in children with chronic kidney disease. J. Clin. Med., 2020, 9(2), 336.
[http://dx.doi.org/10.3390/jcm9020336] [PMID: 31991725]

Zheng, Y.; Tang, Z.; You, L.; Wu, Y.; Liu, J.; Xue, J. Trimethylamine- N -oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis. Ren. Fail., 2020, 42(1), 580-586.
[http://dx.doi.org/10.1080/0886022X.2020.1781170] [PMID: 32576072]

Yin, J.; Liao, S.X.; He, Y.; Wang, S.; Xia, G.H.; Liu, F.T.; Zhu, J.J.; You, C.; Chen, Q.; Zhou, L.; Pan, S.Y.; Zhou, H.W. Dysbiosis of Gut microbiota with reduced trimethylamine-n-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J. Am. Heart Assoc., 2015, 4(11), e002699.
[http://dx.doi.org/10.1161/JAHA.115.002699] [PMID: 26597155]

Haghikia, A.; Li, X.S.; Liman, T.G.; Bledau, N.; Schmidt, D.; Zimmermann, F. Kränkel, N.; Widera, C.; Sonnenschein, K.; Haghikia, A.; Weissenborn, K.; Fraccarollo, D.; Heimesaat, M.M.; Bauersachs, J.; Wang, Z.; Zhu, W.; Bavendiek, U.; Hazen, S.L.; Endres, M.; Landmesser, U. Gut microbiota–dependent trimethylamine N -oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes. Arterioscler. Thromb. Vasc. Biol., 2018, 38(9), 2225-2235.
[http://dx.doi.org/10.1161/ATVBAHA.118.311023] [PMID: 29976769]

Nie, J.; Xie, L.; Zhao, B.; Li, Y.; Qiu, B.; Zhu, F.; Li, G.; He, M.; Wang, Y.; Wang, B.; Liu, S.; Zhang, H.; Guo, H.; Cai, Y.; Huo, Y.; Hou, F.F.; Xu, X.; Qin, X. Serum trimethylamine N-oxide concentration is positively associated with first stroke in hypertensive patients. Stroke, 2018, 49(9), 2021-2028.
[http://dx.doi.org/10.1161/STROKEAHA.118.021997] [PMID: 30354996]

Liang, Z.; Dong, Z.; Guo, M.; Shen, Z.; Yin, D.; Hu, S.; Hai, X. Trimethylamine N-oxide as a risk marker for ischemic stroke in patients with atrial fibrillation. J. Biochem. Mol. Toxicol., 2019, 33(2), e22246.
[http://dx.doi.org/10.1002/jbt.22246] [PMID: 30370581]

Rexidamu, M.; Li, H.; Jin, H.; Huang, J. Serum levels of trimethylamine-N-oxide in patients with ischemic stroke. Biosci. Rep., 2019, 39(6), BSR20190515.
[http://dx.doi.org/10.1042/BSR20190515] [PMID: 31142624]

Zhai, Q.; Wang, X.; Chen, C.; Tang, Y.; Wang, Y.; Tian, J.; Zhao, Y.; Liu, X. Prognostic value of plasma trimethylamine N-oxide levels in patients with acute ischemic stroke. Cell. Mol. Neurobiol., 2019, 39(8), 1201-1206.
[http://dx.doi.org/10.1007/s10571-019-00714-3] [PMID: 31332666]

Hou, L.; Zhang, Y.; Zheng, D.; Shi, H.; Zou, C.; Zhang, H.; Lu, Z.; Du, H. Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke. Neurol. Res., 2020, 42(2), 153-158.
[http://dx.doi.org/10.1080/01616412.2019.1710416] [PMID: 31928326]

Schneider, C.; Okun, J.G.; Schwarz, K.V.; Hauke, J.; Zorn, M.; Nürnberg, C.; Ungerer, M.; Ringleb, P.A.; Mundiyanapurath, S. Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days. Eur. J. Neurol., 2020, 27(8), 1596-1603.
[http://dx.doi.org/10.1111/ene.14253] [PMID: 32282978]

Sun, T.; Zhang, Y.; Yin, J.; Peng, X.; Zhou, L.; Huang, S.; Wen, Y.; Cao, B.; Chen, L.; Li, X.; Yang, W.; Tan, A.; Cheng, J.; Liu, L. Association of gut microbiota-dependent metabolite trimethylamine N-oxide with first ischemic stroke. J. Atheroscler. Thromb., 2021, 28(4), 320-328.
[http://dx.doi.org/10.5551/jat.55962] [PMID: 32641646]

Tan, C.; Wang, H.; Gao, X.; Xu, R.; Zeng, X.; Cui, Z.; Zhu, J.; Wu, Q.; Xia, G.; Zhou, H.; He, Y.; Yin, J. Dynamic changes and prognostic value of gut microbiota-dependent trimethylamine-N-oxide in acute ischemic stroke. Front. Neurol., 2020, 11, 29.
[http://dx.doi.org/10.3389/fneur.2020.00029] [PMID: 32082246]

Wu, C.; Xue, F.; Lian, Y.; Zhang, J.; Wu, D.; Xie, N.; Chang, W.; Chen, F.; Wang, L.; Wei, W.; Yang, K.; Zhao, W.; Wu, L.; Song, H.; Ma, Q.; Ji, X. Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury. Neurology, 2020, 94(7), e667-e677.
[http://dx.doi.org/10.1212/WNL.0000000000008862] [PMID: 31907287]

Tang, W.H.W.; Wang, Z.; Fan, Y.; Levison, B.; Hazen, J.E.; Donahue, L.M.; Wu, Y.; Hazen, S.L. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: Refining the gut hypothesis. J. Am. Coll. Cardiol., 2014, 64(18), 1908-1914.
[http://dx.doi.org/10.1016/j.jacc.2014.02.617] [PMID: 25444145]

Kaysen, G.A.; Johansen, K.L.; Chertow, G.M.; Dalrymple, L.S.; Kornak, J.; Grimes, B.; Dwyer, T.; Chassy, A.W.; Fiehn, O. Associations of trimethylamine N-oxide with nutritional and inflammatory biomarkers and cardiovascular outcomes in patients new to dialysis. J. Ren. Nutr., 2015, 25(4), 351-356.
[http://dx.doi.org/10.1053/j.jrn.2015.02.006] [PMID: 25802017]

Mente, A.; Chalcraft, K.; Ak, H.; Davis, A.D.; Lonn, E.; Miller, R.; Potter, M.A.; Yusuf, S.; Anand, S.S.; McQueen, M.J. The relationship between trimethylamine-N-oxide and prevalent cardiovascular disease in a multiethnic population living in canada. Can. J. Cardiol., 2015, 31(9), 1189-1194.
[http://dx.doi.org/10.1016/j.cjca.2015.06.016] [PMID: 26239008]

Tang, W.H.W.; Wang, Z.; Shrestha, K.; Borowski, A.G.; Wu, Y.; Troughton, R.W.; Klein, A.L.; Hazen, S.L. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J. Card. Fail., 2015, 21(2), 91-96.
[http://dx.doi.org/10.1016/j.cardfail.2014.11.006] [PMID: 25459686]

Trøseid, M.; Ueland, T.; Hov, J.R.; Svardal, A.; Gregersen, I.; Dahl, C.P.; Aakhus, S.; Gude, E.; Bjørndal, B.; Halvorsen, B.; Karlsen, T.H.; Aukrust, P.; Gullestad, L.; Berge, R.K.; Yndestad, A. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J. Intern. Med., 2015, 277(6), 717-726.
[http://dx.doi.org/10.1111/joim.12328] [PMID: 25382824]

Fu, Q.; Zhao, M.; Wang, D.; Hu, H.; Guo, C.; Chen, W.; Li, Q.; Zheng, L.; Chen, B. Coronary plaque characterization assessed by optical coherence tomography and plasma trimethylamine-n-oxide levels in patients with coronary artery disease. Am. J. Cardiol., 2016, 118(9), 1311-1315.
[http://dx.doi.org/10.1016/j.amjcard.2016.07.071] [PMID: 27600460]

Meyer, K.A.; Benton, T.Z.; Bennett, B.; Jacobs, D.R.; Lloyd-Jones, D.M.; Gross, M.D.; Gordon-Larsen, P.; Zeisel, S.H. Abstract P025: Trimethylamine N-oxide not associated with coronary artery calcium in healthy, young adults with normal kidney function: Coronary artery risk development in young adults study, 2000-2011. Circulation, 2016, 133(Suppl. 1), 133.
[http://dx.doi.org/10.1161/circ.133.suppl_1.p025]

Meyer, K.A.; Benton, T.Z.; Bennett, B.J.; Jacobs, D.R., Jr; Lloyd, J.D.M.; Gross, M.D.; Carr, J.J.; Gordon, L.P.; Zeisel, S.H. Microbiota-dependent metabolite trimethylamine N-oxide and coronary artery calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA). J. Am. Heart Assoc., 2016, 5(10), e003970.
[http://dx.doi.org/10.1161/JAHA.116.003970] [PMID: 27792658]

Senthong, V.; Li, X.S.; Hudec, T.; Coughlin, J.; Wu, Y.; Levison, B.; Wang, Z.; Hazen, S.L.; Tang, W.H.W. Plasma trimethylamine N -Oxide, a gut microbe–generated phosphatidylcholine metabolite, is associated with atherosclerotic burden. J. Am. Coll. Cardiol., 2016, 67(22), 2620-2628.
[http://dx.doi.org/10.1016/j.jacc.2016.03.546] [PMID: 27256833]

Senthong, V.; Wang, Z.; Li, X.S.; Fan, Y.; Wu, Y.; Wilson Tang, W.H.; Hazen, S.L. Intestinal microbiota-generated metabolite trimethylamine- N- oxide and 5-year mortality risk in stable coronary artery disease: The contributory role of intestinal microbiota in a COURAGE-like patient cohort. J. Am. Heart Assoc., 2016, 5(6), e002816.
[http://dx.doi.org/10.1161/JAHA.115.002816] [PMID: 27287696]

Senthong, V.; Wang, Z.; Fan, Y.; Wu, Y.; Hazen, S.L.; Tang, W.H.W. Trimethylamine N -oxide and mortality risk in patients with peripheral artery disease. J. Am. Heart Assoc., 2016, 5(10), e004237.
[http://dx.doi.org/10.1161/JAHA.116.004237] [PMID: 27792653]

Skagen, K. Trøseid, M.; Ueland, T.; Holm, S.; Abbas, A.; Gregersen, I.; Kummen, M.; Bjerkeli, V.; Reier, N.F.; Russell, D.; Svardal, A.; Karlsen, T.H.; Aukrust, P.; Berge, R.K.; Hov, J.E.R.; Halvorsen, B.; Skjelland, M. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis. Atherosclerosis, 2016, 247, 64-69.
[http://dx.doi.org/10.1016/j.atherosclerosis.2016.01.033] [PMID: 26868510]

Suzuki, T.; Heaney, LM. Trimethylamine N-oxide and prognosis in acute heart failure. Heart, 2016, 102(11), 841-848.

Suzuki, T.; Heaney, L.M.; Jones, D.J.L.; Ng, L.L. Trimethylamine N-oxide and risk stratification after acute myocardial infarction. Clin. Chem., 2017, 63(1), 420-428.
[http://dx.doi.org/10.1373/clinchem.2016.264853] [PMID: 28062632]

Borisovich, M.A.; Aleksandrovna, I.S.; Mikhailovna, L.Y.; Gennadievna, T.L.; Akylbekovna, T.A.; Moraru, D. Relationship between trimethylamine n-oxide and total cardiovascular risk in the population of central Kazakhstan. Acta Med. Mediter., 2018, 34(1), 59-63.

Li, X.S.; Wang, Z.; Cajka, T.; Buffa, J.A.; Nemet, I.; Hurd, A.G.; Gu, X.; Skye, S.M.; Roberts, A.B.; Wu, Y.; Li, L.; Shahen, C.J.; Wagner, M.A.; Hartiala, J.A.; Kerby, R.L.; Romano, K.A.; Han, Y.; Obeid, S.; Lüscher, T.F.; Allayee, H.; Rey, F.E.; DiDonato, J.A.; Fiehn, O.; Tang, W.H.W.; Hazen, S.L. Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk. JCI Insight, 2018, 3(6), e99096.
[http://dx.doi.org/10.1172/jci.insight.99096] [PMID: 29563342]

Liu, X.; Xie, Z.; Sun, M.; Wang, X.; Li, J.; Cui, J.; Zhang, F.; Yin, L.; Huang, D.; Hou, J.; Tian, J.; Yu, B. Plasma trimethylamine N-oxide is associated with vulnerable plaque characteristics in CAD patients as assessed by optical coherence tomography. Int. J. Cardiol., 2018, 265, 18-23.
[http://dx.doi.org/10.1016/j.ijcard.2018.04.126] [PMID: 29729869]

Svingen, G.F.T.; Zuo, H.; Ueland, P.M.; Seifert, R.; Løland, K.H.; Pedersen, E.R.; Schuster, P.M.; Karlsson, T.; Tell, G.S.; Schartum, H.H.; Olset, H.; Svenningsson, M.; Strand, E.; Nilsen, D.W.; Nordrehaug, J.E.; Dhar, I.; Nygård, O. Increased plasma trimethylamine- N -oxide is associated with incident atrial fibrillation. Int. J. Cardiol., 2018, 267, 100-106.
[http://dx.doi.org/10.1016/j.ijcard.2018.04.128] [PMID: 29957250]

Chou, R.H.; Chen, C.Y.; Chen, I.C.; Huang, H.L.; Lu, Y.W.; Kuo, C.S.; Chang, C.C.; Huang, P.H.; Chen, J.W.; Lin, S.J. Trimethylamine N-oxide, circulating endothelial progenitor cells, and endothelial function in patients with stable angina. Sci. Rep., 2019, 9(1), 4249.
[http://dx.doi.org/10.1038/s41598-019-40638-y] [PMID: 30862856]

Gong, D.; Zhang, L.; Zhang, Y.; Wang, F.; Zhao, Z.; Zhou, X. Gut microbial metabolite trimethylamine N-oxide is related to thrombus formation in atrial fibrillation patients. Am. J. Med. Sci., 2019, 358(6), 422-428.
[http://dx.doi.org/10.1016/j.amjms.2019.09.002] [PMID: 31666184]

Kaburova, A.N.; Poyarkov, S.V.; Makarov, V.V.; Drapkina, O.M.; Uydin, S.M.; Pokrovskaya, M.S.; Koretsky, S.N.; Efimova, I.A.; Matskevich, L.A.; Gomiranova, N.V. 219Serum trimethylamine Noxide levels and 16S rRNA gut microbiota profiling in patients with heart failure and preserved ejection fraction and healthy individuals. Eur. Heart J., 2019, 40(Suppl. 1), ehz747.0060.
[http://dx.doi.org/10.1093/eurheartj/ehz747.0060]

Matsuzawa, Y.; Nakahashi, H.; Konishi, M.; Sato, R.; Kawashima, C.; Kikuchi, S.; Akiyama, E.; Iwahashi, N.; Maejima, N.; Okada, K.; Ebina, T.; Hibi, K.; Kosuge, M.; Ishigami, T.; Tamura, K.; Kimura, K. Microbiota-derived trimethylamine N-oxide predicts cardiovascular risk after STEMI. Sci. Rep., 2019, 9(1), 11647.
[http://dx.doi.org/10.1038/s41598-019-48246-6] [PMID: 31406181]

Reiner, M.F.; Müller, D.; Gobbato, S.; Stalder, O.; Limacher, A.; Bonetti, N.R.; Pasterk, L.; Méan, M.; Rodondi, N.; Aujesky, D.; Angelillo-Scherrer, A.; Matter, C.M.; Lüscher, T.F.; Camici, G.G.; von Eckardstein, A.; Beer, J.H. Gut microbiota-dependent Trimethylamine-N-Oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism. Thromb. Res., 2019, 174, 40-47.
[http://dx.doi.org/10.1016/j.thromres.2018.12.011] [PMID: 30553164]

Roncal, C.; Martínez, A.E.; Orbe, J.; Ravassa, S.; Fernandez, M.A.; Saenz, P.G.; Ugarte, A.; De Mendoza, E.H.A.; Rodriguez, J.A.; Fernández, A.S.; Fernández, A.L.; Oyarzabal, J.; Paramo, J.A. Trimethylamine-N-Oxide (TMAO) predicts cardiovascular mortality in peripheral artery disease. Sci. Rep., 2019, 9(1), 15580.
[http://dx.doi.org/10.1038/s41598-019-52082-z] [PMID: 31666590]

Sheng, Z.; Tan, Y.; Liu, C.; Zhou, P.; Li, J.; Zhou, J.; Chen, R.; Chen, Y.; Song, L.; Zhao, H.; Yan, H. Relation of circulating trimethylamine N-oxide with coronary atherosclerotic burden in patients With ST-segment elevation myocardial infarction. Am. J. Cardiol., 2019, 123(6), 894-898.
[http://dx.doi.org/10.1016/j.amjcard.2018.12.018] [PMID: 30594289]

Tan, Y.; Sheng, Z.; Zhou, P.; Liu, C.; Zhao, H.; Song, L.; Li, J.; Zhou, J.; Chen, Y.; Wang, L.; Qian, H.; Sun, Z.; Qiao, S.; Xu, B.; Gao, R.; Yan, H. Plasma trimethylamine N-oxide as a novel biomarker for plaque rupture in patients with ST-segment–elevation myocardial infarction. Circ. Cardiovasc. Interv., 2019, 12(1), e007281.
[http://dx.doi.org/10.1161/CIRCINTERVENTIONS.118.007281] [PMID: 30599768]

Yu, D.; Shu, X.O.; Rivera, E.S.; Zhang, X.; Cai, Q.; Calcutt, M.W.; Xiang, Y.B.; Li, H.; Gao, Y.T.; Wang, T.J.; Zheng, W. Urinary levels of trimethylamine-N-oxide and incident coronary heart disease: A prospective investigation among urban Chinese adults. J. Am. Heart Assoc., 2019, 8(1), e010606.
[http://dx.doi.org/10.1161/JAHA.118.010606] [PMID: 30606084]

Zheng, L.; Zheng, J.; Xie, Y.; Li, Z.; Guo, X.; Sun, G.; Sun, Z.; Xing, F.; Sun, Y. Serum gut microbe-dependent trimethylamine N-oxide improves the prediction of future cardiovascular disease in a community-based general population. Atherosclerosis, 2019, 280, 126-131.
[http://dx.doi.org/10.1016/j.atherosclerosis.2018.11.010] [PMID: 30508691]

Bin Waleed, K.; Lu, Y.; Liu, Q.; Zeng, F.; Tu, H.; Wei, Y.; Xu, S.; Zhang, Z.; Rongfeng, Y.; Fan, A.; Altaf, A.; Chang, J.; Wang, L. Association of trimethylamine N-oxide with coronary atherosclerotic burden in patients with non-ST-segment elevation myocardial infarction. Medicine, 2020, 99(27), e20794.
[http://dx.doi.org/10.1097/MD.0000000000020794] [PMID: 32629663]

Büttner, P.; Okun, J.G.; Hauke, J.; Holzwirth, E.; Obradovic, D.; Hindricks, G.; Thiele, H.; Kornej, J. Trimethylamine N-oxide in atrial fibrillation progression. Int. J. Cardiol. Heart Vasc., 2020, 29, 100554.
[http://dx.doi.org/10.1016/j.ijcha.2020.100554] [PMID: 32885030]

Dong, Z.X.; Zhang, J.; Luo, Y.C.; Zhao, M.M.; Cai, J.G.; Cheng, S.; Zheng, L.M.; Hai, X. The correlation between trimethylamine N-oxide, lipoprotein ratios, and conventional lipid parameters in patients with unstable angina pectoris. Biosci. Rep., 2020, 40(1), BSR20192657.
[http://dx.doi.org/10.1042/BSR20192657] [PMID: 31894847]

Guo, F.; Zhou, J.; Li, Z.; Yu, Z.; Ouyang, D. The association between trimethylamine n-oxide and its predecessors choline, l-carnitine, and betaine with coronary artery disease and artery stenosis. Cardiol. Res. Pract., 2020, 2020, 1-10.
[http://dx.doi.org/10.1155/2020/5854919] [PMID: 32855821]

Heianza, Y.; Ma, W.; DiDonato, J.A.; Sun, Q.; Rimm, E.B.; Hu, F.B.; Rexrode, K.M.; Manson, J.E.; Qi, L. Long-term changes in gut microbial metabolite trimethylamine N-oxide and coronary heart disease risk. J. Am. Coll. Cardiol., 2020, 75(7), 763-772.
[http://dx.doi.org/10.1016/j.jacc.2019.11.060] [PMID: 32081286]

Hochstrasser, S.R.; Metzger, K.; Vincent, A.M.; Becker, C.; Keller, A.K.J.; Beck, K.; Perrig, S.; Tisljar, K.; Sutter, R.; Schuetz, P.; Bernasconi, L.; Neyer, P.; Marsch, S.; Hunziker, S. Trimethylamine-N-Oxide (TMAO) predicts short- and long-term mortality and poor neurological outcome in out-of-hospital cardiac arrest patients. Clin. Chem. Lab. Med., 2021, 59(2), 393-402.
[http://dx.doi.org/10.1515/cclm-2020-0159] [PMID: 32866111]

Tan, Y.; Zhou, J.; Liu, C.; Zhou, P.; Sheng, Z.; Li, J.; Chen, R.; Song, L.; Zhao, H.; Xu, B.; Gao, R.; Yan, H. Association between plasma trimethylamine N-oxide and neoatherosclerosis in patients with very late stent thrombosis. Can. J. Cardiol., 2020, 36(8), 1252-1260.
[http://dx.doi.org/10.1016/j.cjca.2019.10.041] [PMID: 32595007]

Yazaki, Y.; Aizawa, K.; Israr, M.Z.; Negishi, K.; Salzano, A.; Saitoh, Y.; Kimura, N.; Kono, K.; Heaney, L.; Cassambai, S.; Bernieh, D.; Lai, F.; Imai, Y.; Kario, K.; Nagai, R.; Ng, L.L.; Suzuki, T. Ethnic differences in association of outcomes with trimethylamine N-oxide in acute heart failure patients. ESC Heart Fail., 2020, 7(5), 2373-2378.
[http://dx.doi.org/10.1002/ehf2.12777] [PMID: 32598563]

Zhou, X.; Jin, M.; Liu, L.; Yu, Z.; Lu, X.; Zhang, H. Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction. ESC Heart Fail., 2020, 7(1), 189-194.
[http://dx.doi.org/10.1002/ehf2.12552] [PMID: 31960610]

Zuo, K.; Liu, X.; Wang, P.; Jiao, J.; Han, C.; Liu, Z.; Yin, X.; Li, J.; Yang, X. Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients. BMC Genomics, 2020, 21(1), 526.
[http://dx.doi.org/10.1186/s12864-020-06944-w] [PMID: 32731896]

Li, J.; Sheng, Z.; Tan, Y.; Zhou, P.; Liu, C.; Zhao, H.; Song, L.; Zhou, J.; Chen, R.; Chen, Y.; Yan, H. Association of plasma trimethylamine N-Oxide level with healed culprit plaques examined by optical coherence tomography in patients with ST-Segment elevation myocardial infarction. Nutr. Metab. Cardiovasc. Dis., 2021, 31(1), 145-152.
[http://dx.doi.org/10.1016/j.numecd.2020.06.016] [PMID: 33500103]

Wilson, A.; Teft, W.A.; Morse, B.L.; Choi, Y.H.; Woolsey, S.; DeGorter, M.K.; Hegele, R.A.; Tirona, R.G.; Kim, R.B. Trimethylamine-N-oxide: A novel biomarker for the identification of inflammatory bowel disease. Dig. Dis. Sci., 2015, 60(12), 3620-3630.
[http://dx.doi.org/10.1007/s10620-015-3797-3] [PMID: 26160437]

Kummen, M.; Vesterhus, M. Trøseid, M.; Moum, B.; Svardal, A.; Boberg, K.M.; Aukrust, P.; Karlsen, T.H.; Berge, R.K.; Hov, J.R. Elevated Trimethylamine- N -Oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function. United Eur. Gastroenterol. J.,, 2017, 5(4), 532-541.
[http://dx.doi.org/10.1177/2050640616663453] [PMID: 28588885]

Liu, X.; Liu, H.; Yuan, C.; Zhang, Y.; Wang, W.; Hu, S.; Liu, L.; Wang, Y. Preoperative serum TMAO level is a new prognostic marker for colorectal cancer. Biomarkers Med., 2017, 11(5), 443-447.
[http://dx.doi.org/10.2217/bmm-2016-0262] [PMID: 28621609]

Barrea, L.; Annunziata, G.; Muscogiuri, G.; Di Somma, C.; Laudisio, D.; Maisto, M.; De Alteriis, G.; Tenore, G.; Colao, A.; Savastano, S. Trimethylamine-N-Oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients, 2018, 10(12), 1971.
[http://dx.doi.org/10.3390/nu10121971] [PMID: 30551613]

Liu, Z.Y.; Tan, X.Y.; Li, Q.J.; Liao, G.C.; Fang, A.P.; Zhang, D.M.; Chen, P.Y.; Wang, X.Y.; Luo, Y.; Long, J.A.; Zhong, R.H.; Zhu, H.L. Trimethylamine N-oxide, a gut microbiota-dependent metabolite of choline, is positively associated with the risk of primary liver cancer: A case-control study. Nutr. Metab., 2018, 15(1), 81.
[http://dx.doi.org/10.1186/s12986-018-0319-2] [PMID: 30479648]

Ottiger, M.; Nickler, M.; Steuer, C.; Bernasconi, L.; Huber, A.; Christ, C.M.; Henzen, C.; Hoess, C.; Thomann, R.; Zimmerli, W.; Mueller, B.; Schuetz, P. Gut, microbiota-dependent trimethylamine- N -oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease. Nutrition, 2018, 45, 135-141.e1.
[http://dx.doi.org/10.1016/j.nut.2017.07.001] [PMID: 28870405]

Vogt, N.M.; Romano, K.A.; Darst, B.F.; Engelman, C.D.; Johnson, S.C.; Carlsson, C.M.; Asthana, S.; Blennow, K.; Zetterberg, H.; Bendlin, B.B.; Rey, F.E. The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease. Alzheimers Res. Ther., 2018, 10(1), 124.
[http://dx.doi.org/10.1186/s13195-018-0451-2] [PMID: 30579367]

Coras, R.; Kavanaugh, A.; Boyd, T.; Huynh, D.; Lagerborg, K.A.; Xu, Y.J.; Rosenthal, S.B.; Jain, M.; Guma, M. Choline metabolite, Trimethylamine N-Oxide (TMAO), is associated with inflammation in psoriatic arthritis. Clin. Exp. Rheumatol., 2019, 37(3), 481-484.
[PMID: 30620278]

Gao, X.; Tian, Y.; Randell, E.; Zhou, H.; Sun, G. Unfavorable associations between serum trimethylamine N-oxide and L-carnitine levels with components of metabolic syndrome in the newfoundland population. Front. Endocrinol. (Lausanne), 2019, 10, 168.
[http://dx.doi.org/10.3389/fendo.2019.00168] [PMID: 30972022]

Tan, X.; Liu, Y.; Long, J.; Chen, S.; Liao, G.; Wu, S.; Li, C.; Wang, L.; Ling, W.; Zhu, H. Trimethylamine N -oxide aggravates liver steatosis through modulation of bile acid metabolism and inhibition of farnesoid X receptor signaling in nonalcoholic fatty liver disease. Mol. Nutr. Food Res., 2019, 63(17), 1900257.
[http://dx.doi.org/10.1002/mnfr.201900257] [PMID: 31095863]

Wen, Y.; Peng, L.; Xu, R.; Zang, N.; Huang, Q.; Zhong, M. Maternal serum trimethylamine-N-oxide is significantly increased in cases with established preeclampsia. Pregnancy Hypertens., 2019, 15, 114-117.
[http://dx.doi.org/10.1016/j.preghy.2018.12.001] [PMID: 30825906]

Huang, J.; Liu, L.; Chen, C.; Gao, Y. PCOS without hyperandrogenism is associated with higher plasma trimethylamine N-oxide levels. BMC Endocr. Disord., 2020, 20(1), 3.
[http://dx.doi.org/10.1186/s12902-019-0486-9] [PMID: 31906930]

Huang, X.; Li, Z.; Gao, Z.; Wang, D.; Li, X.; Li, Y.; Mi, C.; Lei, J. Association between risk of preeclampsia and maternal plasma trimethylamine-N-oxide in second trimester and at the time of delivery. BMC Pregnancy Childbirth, 2020, 20(1), 302.
[http://dx.doi.org/10.1186/s12884-020-02997-7] [PMID: 32429856]

León, M.P.; Villamil, R.H.; Li, X.S.; Shih, D.M.; Hui, S.T.; Ocampo, M.E.; López, C.B.; Morán, R.S.; Olivares, A.M.; Grandini, R.P.; Macías, K.L.; González, G.I.;Hernández, P.R.; Gómez, P.F.; Campos, P.F.; Aguilar, S.C.; Larrieta, C.E.; Villarreal, M.T.; Wang, Z.; Lusis, A.J.; Hazen, S.L.; Huertas, V.A.; Canizales, Q.S. Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes. Diabetes Metab., 2021, 47(2), 101183.
[http://dx.doi.org/10.1016/j.diabet.2020.07.010] [PMID: 32791310]

Liu, Y.; Guo, Y.L.; Meng, S.; Gao, H.; Sui, L.J.; Jin, S.; Li, Y.; Fan, S.G. Gut microbiota–dependent Trimethylamine N-oxide are related with hip fracture in postmenopausal women: A matched case-control study. Aging (Albany NY), 2020, 12(11), 10633-10641.
[http://dx.doi.org/10.18632/aging.103283] [PMID: 32482913]

Quan, L.; Yi, J.; Zhao, Y.; Zhang, F.; Shi, X.T.; Feng, Z.; Miller, H.L. Plasma trimethylamine N-oxide, a gut microbe–generated phosphatidylcholine metabolite, is associated with autism spectrum disorders. Neurotoxicology, 2020, 76, 93-98.
[http://dx.doi.org/10.1016/j.neuro.2019.10.012] [PMID: 31704102]

Zhai, Q.; Sun, T.; Sun, C.; Yan, L.; Wang, X.; Wang, Y. High plasma levels of trimethylamine N-oxide are associated with poor outcome in intracerebral hemorrhage patients. Neurol. Sci., 2020, 42(3), 1009-1016.

Zhu, C.; Li, G.; Lv, Z.; Li, J.; Wang, X. Kang, J Association of plasma trimethylamine-N-oxide levels with post-stroke cognitive impairment: A 1-year longitudinal study. Neurological sciences, 2020, 41(1), 57-63.

Oellgaard, J.; Winther, S.A.; Hansen, T.S.; Rossing, P.; von Scholten, B.J. Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer. Curr. Pharm. Des., 2017, 23(25), 3699-3712.
[PMID: 28641532]

Motika, M.S.; Zhang, J.; Cashman, J.R. Flavin-containing monooxygenase 3 and human disease. Expert Opin. Drug Metab. Toxicol., 2007, 3(6), 831-845.
[http://dx.doi.org/10.1517/17425255.3.6.831] [PMID: 18028028]

Koeth, R.A.; Wang, Z.; Levison, B.S.; Buffa, J.A.; Org, E.; Sheehy, B.T.; Britt, E.B.; Fu, X.; Wu, Y.; Li, L.; Smith, J.D.; DiDonato, J.A.; Chen, J.; Li, H.; Wu, G.D.; Lewis, J.D.; Warrier, M.; Brown, J.M.; Krauss, R.M.; Tang, W.H.W.; Bushman, F.D.; Lusis, A.J.; Hazen, S.L. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med., 2013, 19(5), 576-585.
[http://dx.doi.org/10.1038/nm.3145] [PMID: 23563705]

Mingrone, G.; Greco, A.V.; Capristo, E.; Benedetti, G.; Giancaterini, A.; Gaetano, A.D.; Gasbarrini, G. L-carnitine improves glucose disposal in type 2 diabetic patients. J. Am. Coll. Nutr., 1999, 18(1), 77-82.
[http://dx.doi.org/10.1080/07315724.1999.10718830] [PMID: 10067662]

Wang, Z.Y.; Liu, Y.Y.; Liu, G.H.; Lu, H.B.; Mao, C.Y. l -Carnitine and heart disease. Life Sci., 2018, 194, 88-97.
[http://dx.doi.org/10.1016/j.lfs.2017.12.015] [PMID: 29241711]

Marjani, A.; Rafeeinia, A.; Tabandeh, A.; Khajeniazi, S. Metabolic syndrome in preeclampsia women in gorgan. Open Biochem. J., 2014, 8(1), 94-99.
[http://dx.doi.org/10.2174/1874091X01408010094] [PMID: 25553139]

Geng, J.; Yang, C.; Wang, B.; Zhang, X.; Hu, T.; Gu, Y.; Li, J. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway. Biomed. Pharmacother., 2018, 97, 941-947.
[http://dx.doi.org/10.1016/j.biopha.2017.11.016] [PMID: 29136772]

Wang, Z.; Zhao, Y. Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell, 2018, 9(5), 416-431.
[http://dx.doi.org/10.1007/s13238-018-0549-0] [PMID: 29725935]

Zhu, W.; Gregory, J.C.; Org, E.; Buffa, J.A.; Gupta, N.; Wang, Z.; Li, L.; Fu, X.; Wu, Y.; Mehrabian, M.; Sartor, R.B.; McIntyre, T.M.; Silverstein, R.L.; Tang, W.H.W.; DiDonato, J.A.; Brown, J.M.; Lusis, A.J.; Hazen, S.L. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell, 2016, 165(1), 111-124.
[http://dx.doi.org/10.1016/j.cell.2016.02.011] [PMID: 26972052]

Warrier, M.; Shih, D.M.; Burrows, A.C.; Ferguson, D.; Gromovsky, A.D.; Brown, A.L.; Marshall, S.; McDaniel, A.; Schugar, R.C.; Wang, Z.; Sacks, J.; Rong, X.; Vallim, T.A.; Chou, J.; Ivanova, P.T.; Myers, D.S.; Brown, H.A.; Lee, R.G.; Crooke, R.M.; Graham, M.J.; Liu, X.; Parini, P.; Tontonoz, P.; Lusis, A.J.; Hazen, S.L.; Temel, R.E.; Brown, J.M. The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance. Cell Rep., 2015, 10(3), 326-338.
[http://dx.doi.org/10.1016/j.celrep.2014.12.036] [PMID: 25600868]

Heianza, Y.; Sun, D.; Li, X.; DiDonato, J.A.; Bray, G.A.; Sacks, F.M.; Qi, L. Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: The POUNDS Lost trial. Gut, 2019, 68(2), 263-270.
[http://dx.doi.org/10.1136/gutjnl-2018-316155] [PMID: 29860242]

Miao, J.; Ling, A.V.; Manthena, P.V.; Gearing, M.E.; Graham, M.J.; Crooke, R.M.; Croce, K.J.; Esquejo, R.M.; Clish, C.B.; Vicent, D.; Biddinger, S.B. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat. Commun., 2015, 6(1), 6498.
[http://dx.doi.org/10.1038/ncomms7498] [PMID: 25849138]

Shih, D.M.; Wang, Z.; Lee, R.; Meng, Y.; Che, N.; Charugundla, S.; Qi, H.; Wu, J.; Pan, C.; Brown, J.M.; Vallim, T.; Bennett, B.J.; Graham, M.; Hazen, S.L.; Lusis, A.J. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J. Lipid Res., 2015, 56(1), 22-37.
[http://dx.doi.org/10.1194/jlr.M051680] [PMID: 25378658]

Zeng, Y.; Guo, M.; Fang, X.; Teng, F.; Tan, X.; Li, X.; Wang, M.; Long, Y.; Xu, Y. Gut microbiota-derived trimethylamine N-oxide and kidney function: A systematic review and meta-analysis. Adv. Nutr., 2021, 12(4), 1286-1304.
[http://dx.doi.org/10.1093/advances/nmab010] [PMID: 33751019]

Ufnal, M.; Zadlo, A.; Ostaszewski, R. TMAO: A small molecule of great expectations. Nutrition, 2015, 31(11-12), 1317-1323.
[http://dx.doi.org/10.1016/j.nut.2015.05.006] [PMID: 26283574]

Lombardo, M.; Aulisa, G.; Marcon, D.; Rizzo, G.; Tarsisano, M.G.; Di Renzo, L.; Federici, M.; Caprio, M.; De Lorenzo, A. Association of urinary and plasma levels of Trimethylamine N-Oxide (TMAO) with foods. Nutrients, 2021, 13(5), 1426.
[http://dx.doi.org/10.3390/nu13051426] [PMID: 33922680]

Nowiński, A.; Ufnal, M. Trimethylamine N -oxide: A harmful, protective or diagnostic marker in lifestyle diseases? Nutrition, 2018, 46, 7-12.
[http://dx.doi.org/10.1016/j.nut.2017.08.001] [PMID: 29290360]

Meyers, L.D.; Hellwig, J.P.; Otten, J.J. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements; National Academies Press: Washington, DC, 2006.

Flint, H.J.; Duncan, S.H.; Scott, K.P.; Louis, P. Links between diet, gut microbiota composition and gut metabolism. Proc. Nutr. Soc., 2015, 74(1), 13-22.
[http://dx.doi.org/10.1017/S0029665114001463] [PMID: 25268552]

Graf, D.; Di Cagno, R. Fåk, F.; Flint, H.J.; Nyman, M.; Saarela, M.; Watzl, B. Contribution of diet to the composition of the human gut microbiota. Microb. Ecol. Health Dis., 2015, 26(1), 26164.
[PMID: 25656825]

Shi, Z. Gut microbiota: An important link between western diet and chronic diseases. Nutrients, 2019, 11(10), 2287.
[http://dx.doi.org/10.3390/nu11102287] [PMID: 31554269]

Chen, K.; Zheng, X.; Feng, M.; Li, D.; Zhang, H. Gut microbiota-dependent metabolite trimethylamine N-oxide contributes to cardiac dysfunction in western diet-induced obese mice. Front. Physiol., 2017, 8, 139.
[http://dx.doi.org/10.3389/fphys.2017.00139] [PMID: 28377725]

De Filippis, F.; Pellegrini, N.; Vannini, L.; Jeffery, I.B.; La Storia, A.; Laghi, L.; Serrazanetti, D.I.; Di Cagno, R.; Ferrocino, I.; Lazzi, C.; Turroni, S.; Cocolin, L.; Brigidi, P.; Neviani, E.; Gobbetti, M.; O’Toole, P.W.; Ercolini, D. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut, 2016, 65(11), 1812-1821.
[http://dx.doi.org/10.1136/gutjnl-2015-309957] [PMID: 26416813]

Del Chierico, F.; Vernocchi, P.; Dallapiccola, B.; Putignani, L. Mediterranean diet and health: Food effects on gut microbiota and disease control. Int. J. Mol. Sci., 2014, 15(7), 11678-11699.
[http://dx.doi.org/10.3390/ijms150711678] [PMID: 24987952]

Kashyap, P.C.; Chia, N.; Nelson, H.; Segal, E.; Elinav, E. Eds.: Microbiome at the Frontier of Personalized Medicine. Mayo Clinic Proceedings; Elsevier: Amsterdam, Netherlands, 2017.

Ejtahed, H.S.; Hasani, R.S.; Larijani, B. Human microbiome as an approach to personalized medicine. Altern. Ther. Health Med., 2017, 23(6), 8-9.
[PMID: 28987073]

Dehghan, P.; Farhangi, M.A.; Nikniaz, L.; Nikniaz, Z.; Asghari, J.M. Gut microbiota-derived metabolite Trimethylamine N-Oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis. Obes. Rev., 2020, 21(5), e12993.
[http://dx.doi.org/10.1111/obr.12993] [PMID: 32017391]

Ejtahed, H.S.; Angoorani, P.; Soroush, A.R.; Hasani-Ranjbar, S.; Siadat, S.D.; Larijani, B. Gut microbiota-derived metabolites in obesity: A systematic review. Biosci. Microbiota Food Health, 2020, 39(3), 65-76.
[http://dx.doi.org/10.12938/bmfh.2019-026] [PMID: 32775123]

Farhangi, M.A.; Vajdi, M. Novel findings of the association between gut microbiota–derived metabolite trimethylamine N- oxide and inflammation: Results from a systematic review and dose-response meta-analysis. Crit. Rev. Food Sci. Nutr., 2020, 60(16), 2801-2823.
[http://dx.doi.org/10.1080/10408398.2020.1770199] [PMID: 32462890]